Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk Assessment

References

• WHO. Cardiovascular diseases. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed 217, 2019.
   Google Scholar
• WHO. Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk. 2007 Available from: http://www.who.int/cardiovascular_diseases/guidelines/PocketGL.ENGLISH.AFR-D-E.rev1.pdf?ua=1. Accessed 915, 2018.
   Google Scholar
• Labarthe DR, Dunbar SB. Global cardiovascular health promotion and disease prevention: 2011 and beyond. Circulation. 2012;125(21):2667–2676. doi:10.1161/CIRCULATIONAHA.111.08772622644371
   PubMed Web of Science ®Google Scholar
• Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999;100(13):1481–1492. doi:10.1161/01.CIR.100.13.148110500053
   PubMed Web of Science ®Google Scholar
• Cardiovascular disease risk assessment for primary prevention: our approach. 2019 Available from: https://www.uptodate.com/contents/cardiovascular-disease-risk-assessment-for-primary-prevention-our-approach. Accessed 210, 2019.
   Google Scholar
• Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health Med. 2003;25(2):144–153. doi:10.1093/pubmed/fdg03012848404
   PubMedGoogle Scholar
• Ifeanyi Chiazor E, Evans M, van Woerden H, Oparah AC. A systematic review of community pharmacists’ interventions in reducing major risk factors for cardiovascular disease. Value Health Reg Issues. 2015;7:9–21. doi:10.1016/j.vhri.2015.03.00229698158
   PubMedGoogle Scholar
• Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41(11):1770–1781. doi:10.1345/aph.1K31117925496
   PubMed Web of Science ®Google Scholar
• Sinclair HK, Bond CM, Stead LF. Community pharmacy personnel interventions for smoking cessation. Cochrane Database Syst Rev. 2004;(1):CD003698.14974031
   PubMedGoogle Scholar
• Tsuyuki RT, Al Hamarneh YN, Jones CA, Hemmelgarn BR. The effectiveness of pharmacist interventions on cardiovascular risk: the multicenter randomized controlled RxEACH trial. J Am Coll Cardiol. 2016;67(24):2846–2854. doi:10.1016/j.jacc.2016.03.52827058907
   PubMed Web of Science ®Google Scholar
• McNamara KP, O’reilly SL, Dunbar JA, et al. A pilot study evaluating multiple risk factor interventions by community pharmacists to prevent cardiovascular disease: the PAART CVD pilot project. Ann Pharmacother. 2012;46(2):183–191. doi:10.1345/aph.1Q57222318928
   PubMed Web of Science ®Google Scholar
• Santschi V, Chiolero A, Burnand B, Colosimo AL, Paradis G. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med. 2011;171(16):1441–1453. doi:10.1001/archinternmed.2011.39921911628
   PubMedGoogle Scholar
• El Hajj MS, Mahfoud ZR, Al Suwaidi J, Alkhiyami D, Alasmar AR. Role of pharmacist in cardiovascular disease-related health promotion and in hypertension and dyslipidemia management: a cross-sectional study in the State of Qatar. J Eval Clin Pract. 2016;22(3):329–340. doi:10.1111/jep.1247726552842
   PubMed Web of Science ®Google Scholar
• Zolezzi M, Abdallah O, Kheir N, Abdelsalam AG. Evaluation of community pharmacists’ preparedness for the provision of cardiovascular disease risk assessment and management services: a study with simulated patients. Res Soc Admin Pharm. 2019;15(3):252–259.
   PubMed Web of Science ®Google Scholar
• Fahs IM, Hallit S, Rahal MK, Malaeb DN. The community pharmacist’s role in reducing cardiovascular risk factors in lebanon: a longitudinal study. Med Prin Pract. 2018;27(6):508–514. doi:10.1159/000490853
   Web of Science ®Google Scholar
• Jahangard-rafsanjani Z, Hakimzadeh N, Sarayani A, et al. A community pharmacy-based cardiovascular risk screening service implemented in Iran. Pharm Pract (Granada). 2017;15(2):919.28690693
   PubMed Web of Science ®Google Scholar
• Anderson TJ, Gregoire J, Pearson GJ, et al. 2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2016;32(11):1263–1282. doi:10.1016/j.cjca.2016.07.51027712954
   PubMed Web of Science ®Google Scholar
• Goff DC Jr, Lloyd-jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S49–S73. doi:10.1161/01.cir.0000437741.48606.9824222018
   PubMed Web of Science ®Google Scholar
• Ministry of Public Health (MOPH), Doha Q. Clinical guidelines for the state of Qatar. Atherosclerotic cardiovascular disease risk assessment and management. 2016 Available from: https://www.moph.gov.qa/health-strategies/Documents/Guidelines/Guideline-ASCVD risk assessment and managementv1-1FINAL.pdfMOPH. Accessed 915, 2018.
   Google Scholar
• Zealand. MoHN. Cardiovascular Disease Risk Assessment and Management for Primary Care. Wellington: Ministry of Health; 2018.
   Google Scholar
• ASC. 2018 Available from: https://articulate.com/360. Accessed 915, 2018.
   Google Scholar
• Kirkpatrick DL, Kirkpatrick JD. Evaluation of Training Programs: The Four Levels. San Francisco (CA): Berrett-Koehler Publishers; 1994.
   Google Scholar
• Agness CF, Huynh D, Brandt N. An introductory pharmacy practice experience based on a medication therapy management service model. Am J Pharm Educ. 2011;75(5):82.21829256
   PubMed Web of Science ®Google Scholar
• Bloom BS. Effects of continuing medical education on improving physician clinical care and patient health: a review of systematic reviews. Int j Technol Assess Health Care. 2005;21(3):380–385.16110718
   PubMed Web of Science ®Google Scholar
• Ebn Ahmady A, Barker M, Fahim M, Dragonetti R, Selby P. Evaluation of web-based continuing professional development courses: aggregate mixed-methods model. JMIR Med Educ. 2017;3(2):e19. doi:10.2196/mededu.599329054834
   PubMedGoogle Scholar
• Moore DE Jr, Green JS, Gallis HA. Achieving desired results and improved outcomes: integrating planning and assessment throughout learning activities. J Contin Educ Health Prof. 2009;29(1):1–15. doi:10.1002/chp.2000119288562
   PubMed Web of Science ®Google Scholar
• Wilbur K, Shabana S, Maraghi F, ElMubark A, Kheir N. An evaluation of the translation of continuing education into diabetes public health care by pharmacists. Int J Clin Pharm. 2017;39(4):774–782. doi:10.1007/s11096-017-0477-828500437
   PubMed Web of Science ®Google Scholar
• Abdulghani HM, Shaik SA, Khamis N, et al. Research methodology workshops evaluation using the Kirkpatrick’s model: translating theory into practice. Med Teach. 2014;36(Suppl 1):S24–S29. doi:10.3109/0142159X.2014.88601224617780
   PubMed Web of Science ®Google Scholar
• Gheewala PA, Peterson GM, Zaidi ST, Bereznicki L, Jose MD, Castelino RL. A web-based training program to support chronic kidney disease screening by community pharmacists. Int J Clin Pharm. 2016;38(5):1080–1086. doi:10.1007/s11096-016-0330-527329381
   PubMed Web of Science ®Google Scholar
• Keller DR, O’dell DV, Skochelak SE, Cochran GL, Shull SJ, Gjerde CJ. Teaching the basics of clinical pharmaceutical care: innovative pharmacy workshops at the University of Wisconsin and the University of Nebraska. Fam Med. 2004;36(Suppl):S89–S92.14961409
   PubMed Web of Science ®Google Scholar
• Mehra IV, Wuller CA. Evaluation of a pilot clinical skills workshop series for community pharmacists. Am J Pharm Educ. 1998;62:136–141.
   Web of Science ®Google Scholar
• Crea KA. Practice skill development through the use of human patient simulation. Am J Pharm Educ. 2011;75(9):188. doi:10.5688/ajpe75918822171116
   PubMed Web of Science ®Google Scholar
• Fakeye TO, Adisa R, Erhun WO. Developing a model for teaching and learning clinical pharmacy components of the pharmacy curriculum in Nigeria. Pharm Educ. 2017;17:60–66.
   Web of Science ®Google Scholar
• Garcia Corpas JP, Ocana Arenas A, Gonzalez Garcia L, et al. Changes in knowledge after attending a community pharmacists’ asthma workshop. Pharm Pract (Granada). 2006;4(3):139–142.25214901
   PubMedGoogle Scholar
• Nguyen TS, Nguyen TLH, Van Pham TT, Hua S, Ngo QC, Li SC. Pharmacists’ training to improve inhaler technique of patients with COPD in Vietnam. Int J Chron Obstruct Pulmon Dis. 2018;13:1863–1872. doi:10.2147/COPD.S16382629928117
   PubMed Web of Science ®Google Scholar
• Bolesta S, Trombetta DP, Longyhore DS. Pharmacist instruction of physical assessment for pharmacy students. Am J Pharm Educ. 2011;75(2):29. doi:10.5688/ajpe7522921519419
   PubMed Web of Science ®Google Scholar
• Hess R, Hagemeier NE, Blackwelder R, Rose D, Ansari N, Branham T. Teaching communication skills to medical and pharmacy students through a blended learning course. Am J Pharm Educ. 2016;80(4):64. doi:10.5688/ajpe8046427293231
   PubMed Web of Science ®Google Scholar
• Garrison DR, Kanuka H. Blended learning: uncovering its transformative potential in higher education. Internet High Educ. 2004;7(2):95–105. doi:10.1016/j.iheduc.2004.02.001
   Google Scholar
• Crouch MA. An advanced cardiovascular pharmacotherapy course blending online and face-to-face instruction. Am J Pharm Educ. 2009;73(3):51. doi:10.5688/aj73035119564994
   PubMedGoogle Scholar
• Tangiisuran B, Tye SC, Tan KW. Implementation and assessment of flipped classroom learning on medication distribution system to pharmacy undergraduates. Pharm Educ. 2017;17(1):109–114.
   Web of Science ®Google Scholar
• Vegter S, Oosterhof P, van Boven JF, Stuurman-bieze AG, Hiddink EG, Postma MJ. Improving adherence to lipid-lowering therapy in a community pharmacy intervention program: a cost-effectiveness analysis. J Manage Care Spec Pharm. 2014;20(7):722–732. doi:10.18553/jmcp.2014.20.7.722
   PubMed Web of Science ®Google Scholar
• Cheema E, Sutcliffe P, Singer DR. The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2014;78(6):1238–1247. doi:10.1111/bcp.1245224966032
   PubMed Web of Science ®Google Scholar
• Zeng L, Li Y, Zhang L, et al. Guideline use behaviours and needs of primary care practitioners in China: a cross-sectional survey. BMJ Open. 2017;7(9):e015379. doi:10.1136/bmjopen-2016-015379
   Web of Science ®Google Scholar
• Rauh S, Arnold D, Braga S, et al. Challenge of implementing clinical practice guidelines. Getting ESMO’s guidelines even closer to the bedside: introducing the ESMO Practising Oncologists’ checklists and knowledge and practice questions. ESMO Open. 2018;3(5):e000385. doi:10.1136/esmoopen-2018-00038530094071
   PubMed Web of Science ®Google Scholar
• Carbonaro M, King S, Taylor E, Satzinger F, Snart F, Drummond J. Integration of e-learning technologies in an interprofessional health science course. Med Teach. 2008;30(1):25–33. doi:10.1080/0142159070175345018278648
   PubMed Web of Science ®Google Scholar
• Pahinis K, Stokes CW, Walsh TF, Cannavina G. Evaluating a blended-learning course taught to different groups of learners in a dental school. J Dent Educ. 2007;71(2):269–278.17314389
   PubMed Web of Science ®Google Scholar
• Shaw T, Long A, Chopra S, Kerfoot BP. Impact on clinical behavior of face-to-face continuing medical education blended with online spaced education: a randomized controlled trial. J Contin Educ Health Prof. 2011;31(2):103–108. doi:10.1002/chp.2011321671276
   PubMed Web of Science ®Google Scholar